{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:17:29Z","timestamp":1776745049966,"version":"3.51.2"},"reference-count":51,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T00:00:00Z","timestamp":1107820800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Veterinary Medicine, Series B"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>A total of 50<jats:italic>Staphylococcus intermedius<\/jats:italic>strains isolated in France from canine pyodermas in 2002 were investigated for their susceptibility to various antimicrobial drugs. Antimicrobial susceptibility was assessed using a 2\u2010fold serial dilution method in Mueller\u2010Hinton agar, and the minimal inhibitory concentrations (MICs) were determined. About 62% of the 50 strains tested were producers of<jats:italic>\u03b2<\/jats:italic>\u2010lactamase and categorized as penicillin\u2010resistant. About 26% demonstrated resistance to sulphonamides, 46% to oxytetracycline, 30% to chloramphenicol, 28% to streptomycin, kanamycin, neomycin or erythromycin, 22% to clindamycin, 6% to doxycycline, 2% to gentamicin, enrofloxacin, marbofloxacin or pradofloxacin. Acquired resistance was not observed to a clavulanic acid\u2013amoxicillin combination, oxacillin, cephalosporins (cephalexin, ceftiofur and cefquinome), trimethoprim, a sulphamethoxazole\u2013trimethoprim combination and florfenicol. About 42% were simultaneously resistant to three or more antimicrobial classes (multiresistance). All isolates with acquired resistance to erythromycin were also resistant to streptomycin and neomycin\/kanamycin. About 22% of isolates exhibited cross\u2010resistance between erythromycin and clindamycin and all clindamycin\u2010resistant isolates also exhibited resistance to erythromycin. Resistance to penicillin, oxytetracycline and chloramphenicol was also positively associated with resistance to erythromycin and streptomycin.<\/jats:p>","DOI":"10.1111\/j.1439-0450.2004.00816.x","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T21:08:19Z","timestamp":1107896899000},"page":"25-31","source":"Crossref","is-referenced-by-count":61,"title":["Antimicrobial Drug Susceptibility of<i>Staphylococcus intermedius<\/i>Clinical Isolates from Canine Pyoderma"],"prefix":"10.1111","volume":"52","author":[{"given":"J.\u2010P.","family":"Ganiere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Medaille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mangion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,2,8]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"37","article-title":"Antimicrobial susceptibility of staphylococci isolated from various disease conditions in dogs: a further survey","volume":"25","author":"Barrs V. R.","year":"1995","journal-title":"Aust. Vet. Pract."},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1135(00)00347-3"},{"key":"e_1_2_9_4_1","first-page":"40","article-title":"New trends in systemic antibiotherapy of bacterial skin disease in dogs","volume":"18","author":"Carlotti D. N.","year":"1996","journal-title":"Suppl. Compend. Contin. Educ. Pract. Vet."},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1999.tb03077.x"},{"key":"e_1_2_9_6_1","first-page":"995","article-title":"Choosing a treatment course for dogs with pyoderma","volume":"83","author":"Codner E. C.","year":"1988","journal-title":"Vet. Med."},{"issue":"1","key":"e_1_2_9_7_1","first-page":"155","article-title":"In vitro activity of enrofloxacin, marbofloxacin, orbifloxacin and ciprofloxacin against clinical strains of Staphylococcus intermedius isolated from dogs in Portugal","volume":"26","author":"Coelho\u2010Baptista B.","year":"2003","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"e_1_2_9_8_1","first-page":"156","article-title":"M\u00e9thode de d\u00e9termination de la CMI en milieu solide pour les bact\u00e9ries a\u00e9robies \u00e0 croissance rapide","volume":"8","author":"Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (CA\u2010SFM)","year":"1993","journal-title":"Bull. Soc. Fr. Microbiol."},{"key":"e_1_2_9_9_1","unstructured":"Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (CA\u2010SFM) 2004:Communiqu\u00e9 2004.http:\/\/www.sfm.asso.fr(accessed 1 February 2004)."},{"key":"e_1_2_9_10_1","first-page":"124","article-title":"Species of Staphylococcus isolated from animal infections","volume":"74","author":"Cox H. T.","year":"1984","journal-title":"Cornell Vet."},{"key":"e_1_2_9_11_1","first-page":"747","article-title":"Temporal study of staphylococcal species on healthy dogs","volume":"49","author":"Cox H. T.","year":"1988","journal-title":"Am. J. Vet. Res."},{"key":"e_1_2_9_12_1","first-page":"695","article-title":"Antimicrobial therapy of skin and ear infections","volume":"37","author":"Dowling P. M.","year":"1996","journal-title":"Can. Vet. J."},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.2001.00247.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2004.02.002"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2370(97)00076-4"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2460\/ajvr.1999.60.12.1526","article-title":"Methicillin resistance among staphylococci isolated from dogs","volume":"60","author":"Gortel K.","year":"1996","journal-title":"Am. J. Vet. Res."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(11)80545-1"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2003.09.021"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/08910609409141358"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.1995.tb00421.x"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.151.20.600"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(02)00369-9"},{"key":"e_1_2_9_23_1","first-page":"1526","article-title":"Detection of \u03b2\u2010lactamase produced by Staphylococcus intermedius","volume":"46","author":"Hoskins J. D.","year":"1985","journal-title":"Am. J. Vet. Res."},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0007-1935(87)90002-9"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00179.x"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.2.615-618.2004"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00366918"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1991.tb00127.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1996.tb00242.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00187.x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00183.x"},{"key":"e_1_2_9_32_1","first-page":"229","article-title":"Frequency and antimicrobial susceptibility of Staphylococcus species isolated from canine pyodermas","volume":"47","author":"Medleau L.","year":"1986","journal-title":"Am. J. Vet. Res."},{"key":"e_1_2_9_33_1","first-page":"M31","volume-title":"Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2002"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1992.tb00147.x"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00176.x"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.146.6.151"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0147-9571(97)00026-X"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.5326\/0380407"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.2.163"},{"key":"e_1_2_9_40_1","first-page":"107","article-title":"Antimicrobial drug use and resistance in dogs","volume":"43","author":"Prescott J. F.","year":"2002","journal-title":"Can. Vet. J."},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0450.2003.00672.x"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-002-0788-z"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.1993.tb00378.x"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(94)00092-B"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1135(98)00234-X"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2530-2533.2000"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1997.d01-8.x"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.63.357"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.5.4.387"},{"issue":"1","key":"e_1_2_9_50_1","first-page":"160","article-title":"Clinical efficacy and safety of pradofloxacin in the treatment of canine pyoderma and wound infections under field conditions","volume":"26","author":"Stephan B.","year":"2003","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.1.1"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2001129"}],"container-title":["Journal of Veterinary Medicine, Series B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0450.2004.00816.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0450.2004.00816.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T06:34:21Z","timestamp":1734935661000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0450.2004.00816.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1439-0450.2004.00816.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0450.2004.00816.x","archive":["Portico"],"relation":{},"ISSN":["0931-1793"],"issn-type":[{"value":"0931-1793","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}